MRSA is a significant infection which occurs in hospitals and the community. It is a major issue for health care systems in all countries. There are many contributing factors, including the use of antibiotics and the control of infection in our hospitals.
MRSA is part of the broader issue of anti-microbial resistance which is being addressed in a number of ways. Guidelines for acute hospitals and other facilities in relation to the control of MRSA were developed and circulated to health boards and other relevant parties in 1995. In 1999 a North-South study of MRSA prevalence was undertaken, under the direction of the Eastern Regional Health Authority. This was a follow-up to a previous study carried out in 1995. This study provided much useful data and also made a range of recommendations for the control of MRSA. This included identification of a wide range of issues which needed to be addressed at hospital level. The guidelines issued in 1995 suggest a variety of options for nursing patients with MRSA but did not state single rooms were essential.
In 1999 my Department also asked the National Disease Surveillance Centre to evaluate the problem of anti-microbial resistance in Ireland and formulate a strategy for the future. The NDSC has given detailed consideration to these issues and drawn up a strategy for the control of anti-microbial resistance in Ireland, SARI, which I launched on 19 June last. This report contains a wide range of detailed recommendations to address the issues, including those referred to by the Deputy. These can be grouped into the following four categories: surveillance of resistance and antibiotic use; hygiene and prevention of infection; judicious use of antibiotics in hospitals and the community; and education of health care workers, patients and the general public.
I welcome the recommendations in this report and I am committed to ensuring their implementation. Tackling the problem of anti-microbial resistance is a multi-faceted issue which will require action on a number of fronts. As a first step, in the current year £2 million has been provided for the health boards for anti-microbial resistance measures, taking into account the recommendations in SARI and the North-South study of MRSA in Ireland 1999.
The boards have been asked to address, in particular, infection control strategies and staffing in both hospitals and the community, the development of surveillance systems for the collection of anti-microbial resistance data and information on antibiotic prescribing in hospitals. In addition, funding has been provided for the establishment of an MRSA reference laboratory at St. James's Hospital, Dublin, which, it is envisaged, will come into operation later this year.